AI Verdict
FACTW has stronger fundamentals based on our AI analysis.
FATE vs FACTW Fundamental Comparison
| Metric | FATE | FACTW |
|---|---|---|
| Revenue | $6.6M | $27,824.0 |
| Net Income | $-136.3M | $5.0M |
| Net Margin | -2,051.1% | 18,033.1% |
| ROE | -65.8% | N/A |
| ROA | -42.7% | 2.7% |
| Current Ratio | 5.79x | 27.11x |
| Debt/Equity | 0.07x | N/A |
| EPS | $-1.15 | $-0.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
FATE vs FACTW: Frequently Asked Questions
Is FATE or FACTW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), FACTW has stronger fundamentals. FATE is rated STRONG SELL (92% confidence) while FACTW is rated STRONG SELL (95% confidence). This is not investment advice.
How does FATE compare to FACTW fundamentally?
FATE THERAPEUTICS INC has ROE of -65.8% vs FACT II Acquisition Corp.'s N/A. Net margins are -2,051.1% vs 18,033.1% respectively.
Which stock pays higher dividends, FATE or FACTW?
FATE has a dividend yield of N/A or no dividend while FACTW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in FATE or FACTW for long term?
For long-term investing, consider that FATE has STRONG SELL rating with 92% confidence, while FACTW has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about FATE vs FACTW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For FATE vs FACTW, the AI consensus favors FACTW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.